J. Wang

Efficacy and safety of avelumab plus axitinib in elderly patients with advanced renal cell carcinoma: extended follow-up results from JAVELIN Renal 101

R. Motzer, H. Miyake, B. Rini, 2022, ESMO open.

Patient-Reported Utility on Pembrolizumab (Pembro) and Ipilimumab (Ipi) among Ipi Naïve Patients with Advanced Melanoma

D. Hille, W. Zhou, K. Stevinson, 2016 .

Establishment and maintenance of an optimal chiral surface in cinchona-modified 1% Pt/Al2O3 for enantioselective hydrogenation of α-keto esters

Yong-kui Sun, J. Wang, C. LeBlond, 2000 .

Extended follow-up from JAVELIN Renal 101: subgroup analysis of avelumab plus axitinib versus sunitinib by the International Metastatic Renal Cell Carcinoma Database Consortium risk group in patients with advanced renal cell carcinoma

R. Motzer, M. B. Atkins, J. Larkin, 2023, ESMO open.

Cost-Effectiveness of Pembrolizumab for Unresectable Metastatic Melanoma After Progression with Ipilimumab in England.

C. Praet, R. Aguiar-Ibáñez, J. Pellissier, 2015, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.